P34 Low incidence of adverse liver events in a real-world cohort of patients diagnosed with liver disease via a community diagnostic pathway

Abstract

BackgroundCommunity liver diagnostic pathways use non-invasive liver fibrosis tests to identify patients with compensated alcohol-related liver disease (ArLD) and non-alcohol related fatty liver disease (NAFLD).1 However, the longitudinal association between...